Download video

Definitive Diagnosis of Pneumocystis Pneumonia

115 views

MBBS NAIJA

8 years ago

Definitive Diagnosis of Pneumocystis Pneumonia

Definitive Diagnosis of Pneumocystis Pneumonia

Defintion of Cancer 2
1:01
Defintion of Cancer 2
by Clazified
CHEK2 Functions Beyond DNA Damage Response | Oncotarget
2:21
CHEK2 Functions Beyond DNA Damage Response | Oncotarget
by Oncotarget
Result022 P226 A2B3C0D0E0F0
0:31
Result022 P226 A2B3C0D0E0F0
by filmpersonalitytest
DUTRENEO Trial
3:00
DUTRENEO Trial
by European Association of Urology
Neurodegenerative diseases ck2
29:10
Neurodegenerative diseases ck2
by Dr kevin
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
HL2SD++ test video
4:05
HL2SD++ test video
by the ultimate sigma medic
An ongoing Phase I\/II dose-finding study of ZN-d5 for R\/R AL amyloidosis
0:48
An ongoing Phase I\/II dose-finding study of ZN-d5 for R\/R AL amyloidosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
CUDC907 Promotes Apoptosis of NF2 Schwannoma Cells | Oncotarget
1:56
CUDC907 Promotes Apoptosis of NF2 Schwannoma Cells | Oncotarget
by Oncotarget
CD80: Amplifying Immune Activation Through Co-Stimulatory Pathways
14:44
CD80: Amplifying Immune Activation Through Co-Stimulatory Pathways
by Assay Genie
Duchenne Muscular Dystrophy (DMD) - Causes, Symptoms, Diagnosis, Treatment | Dr. Khalil Ur Rehman
8:16
Duchenne Muscular Dystrophy (DMD) - Causes, Symptoms, Diagnosis, Treatment | Dr. Khalil Ur Rehman
by Dr. Khalil Ur Rehman PT
Full Recording of the October 2023 ICARE Genetics Case Conference
1:07:31
Full Recording of the October 2023 ICARE Genetics Case Conference
by Inherited Cancer Registry (ICARE)
Docplexus Health Minute Episode - 228
1:19
Docplexus Health Minute Episode - 228
by Docplexus
A Phase II protocol for a safe combination of chemotherapy for patients with BPDCN
1:23
A Phase II protocol for a safe combination of chemotherapy for patients with BPDCN
by VJHemOnc – Video Journal of Hematology \& HemOnc
Swedish BioFINDER-2: investigating the diagnostic accuracy of p-tau217 for Alzheimer’s disease
1:07
Swedish BioFINDER-2: investigating the diagnostic accuracy of p-tau217 for Alzheimer’s disease
by VJDementia
A Phase II study of nivolumab plus brentuximab vedotin in early-stage classic Hodgkin lymphoma
4:12
A Phase II study of nivolumab plus brentuximab vedotin in early-stage classic Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Clinical Trial Achieves 60% Reduction in the Risk of Tumor Recurrence
1:11
Clinical Trial Achieves 60% Reduction in the Risk of Tumor Recurrence
by Targeted Oncology
Addition of inotuzumab to alloSCT conditioning regimen in relapsed CD22 (+) lymphoid malignancies
2:19
Addition of inotuzumab to alloSCT conditioning regimen in relapsed CD22 (+) lymphoid malignancies
by VJHemOnc – Video Journal of Hematology \& HemOnc
NKT2152, an oral HIF-2α inhibitor, in pre-treated advanced clear cell renal carcinoma
1:31
NKT2152, an oral HIF-2α inhibitor, in pre-treated advanced clear cell renal carcinoma
by VJOncology
GMT20220316 225207 Recording 1920x1080
51:32
GMT20220316 225207 Recording 1920x1080
by Fuse Medical
A Phase II study of low-dose subcutaneous decitabine in myelofibrosis
1:07
A Phase II study of low-dose subcutaneous decitabine in myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
12-6-2024 - 52 y\/o F with history of HTN, DM2, and CKD complicated by nephrotic range proteinuria...
41:55
12-6-2024 - 52 y\/o F with history of HTN, DM2, and CKD complicated by nephrotic range proteinuria...
by WashU Medicine Department of Medicine
Incidence and clinical outcomes of erythrocytosis associated with SGLT2 inhibitors
5:00
Incidence and clinical outcomes of erythrocytosis associated with SGLT2 inhibitors
by VJHemOnc – Video Journal of Hematology \& HemOnc